Given this important observation and the clear association of AIMp1 with TH1 immune processes, we analyzed the relationship between AIMP1 expression and patient outcome among the nearly 9,000 primary tumor samples in the pan-cancer TCGA database that could be linked to outcomes data. The gene discussed is AIMP1; the disease is cancer.